QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

PCVX

QT70Vaxcyte, Inc.
NASDAQ·Healthcare·Biotechnology·USA
Latest market price
51.44
+0.77+1.52%
OverviewShort InterestFilings
PCVXQT70Vaxcyte, Inc.·NASDAQ
OverviewShort InterestFilings
51.44+1.52%
TA
Loading chart...
Screen all →
VRTX-1.60%$451.63REGN+0.33%$609.94ARGX-1.63%$877.72ALNY-1.64%$278.09RVMD+3.31%$162.99MRNA+3.50%$63.96UTHR-2.70%$536.59BNTX-1.44%$90.89
Snapshot
Index-P/E-EPS (ttm)
-
Insider Own1.15%
Shs Outstand144.40M
Perf Week8.78%
Market Cap7.32BForward P/E-EPS next Y-6.67Insider Trans-0.01%Shs Float-Perf Month5.45%
Enterprise Value7.17BPEG0.16EPS next Q-1.99Inst Own-Short Float-Perf Quarter-4.71%
Income-979696830.00P/S0.00EPS this Y-Inst Trans-Short Ratio-Perf Half Y17.79%
Sales-P/B2.36EPS next Y18.01%ROA-28.27%Short Interest-Perf YTD11.49%
Book/sh20.75P/C-EPS next 5Y-ROE-32.51%52W High65.00 -20.86%Perf Year52.91%
Cash/sh12.03P/FCF-EPS past 3/5Y-ROIC-34.98%52W Low29.08 76.89%Perf 3Y-
Dividend Est.-EV/EBITDA-7.79Sales past 3/5Y-Gross Margin0.00%Volatility3.21% 2.84%Perf 5Y-
Dividend TTM-EV/Sales0.00EPS Y/Y TTM-81.05%Oper. Margin0.00%ATR (14)2.25Perf 10Y-
Dividend Ex-Date-Quick Ratio7.49Sales Y/Y TTM-Profit Margin0.00%RSI (14)54.64Recom2.00
Dividend Gr. 3/5Y-Current Ratio7.49EPS Q/Q-121.15%SMA205.84%Beta1.03Target Price89.00
Payout0.00%Debt/Eq0.04Sales Q/Q-SMA50-4.24%Rel Volume1.96Prev Close50.67
Employees414LT Debt/Eq0.08EarningsAug 05SMA2004.86%Avg Volume1.44MPrice51.44
IPO DateJun 12, 2020Option/ShortYes / YesEPS/Sales Surpr.-29.65% -Net Debt/EBITDA0.16Volume2,837,023Change1.52%
Analyst Ratings
DateActionAnalystRatingTarget
Nov-19-25ReiteratedLeerink PartnersOutperform$135 → $77
Nov-06-24ReiteratedJefferiesBuy$129 → $146
Nov-06-24ReiteratedLeerink PartnersOutperform$153 → $135
Sep-10-24ReiteratedMizuho Securities$113 → $163
Sep-04-24ReiteratedBank of America Securities$101 → $140
Sep-03-24ReiteratedMizuho Securities$113
Sep-03-24ReiteratedLeerink PartnersOutperform$60 → $153
Sep-03-24ReiteratedBTIGBuy$98 → $160
Sep-03-24ReiteratedJefferiesBuy$129
Aug-07-24ReiteratedBTIGBuy$69 → $98
Latest News
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
FY 2017
12/31/2017
Total Revenue
000
Upgrade your experience to unlock full historical data
Cost of Goods Sold Incl. D&A000
Gross Profit000
Selling, General and Administrative Excl. Other1299361
Research and Development794477332
Other Operating Expense1075
Operating Income-924-570-468
Interest Expense
000
Unusual Expense
———
Non-Operating Income (Expense)-157-106-66
Net Income Before Taxes-767-464-402
Income Taxes
000
Consolidated Net Income-767-464-402
Net Income From Continuing Operations-767-464-402
Net Income-767-464-402
EPS (Recurring)-5.63-3.80-4.14
EPS (Basic, Before Extraordinaries)-5.63-3.80-4.14
EPS (Diluted)-5.63-3.80-4.14
EBITDA-742-448-392
Other After Tax Adjustments
———
Stock Option Compensation Expense
———
Price To Earnings Ratio
———
Price To Sales Ratio
———
Gross Margin
———
Operating Margin
———
Net Margin
———
Shares Outstanding13612297
Market Capitalization6,275——
Operating Lease Expense
———
Insider Trading Volume
$53.58$48.95$44.32$39.69$35.06● Close Price0.00M0.25M0.51M0.76M1.01MUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Wassil JimCHIEF OPERATING OFFICERMay 01 '26Sale56.832,250127,870160,744May 01 12:00 AM
Cowan ElviaSVP, Finance & CAOApr 07 '26Option Exercise25.926,000155,52093,068Apr 08 12:00 AM
Cowan ElviaSVP, Finance & CAOApr 07 '26Sale60.003,000180,00028,975Apr 08 12:00 AM
Wassil JimCHIEF OPERATING OFFICERApr 01 '26Sale58.432,250131,476162,994Apr 03 12:00 AM
Cowan ElviaSVP, Finance & CAOMar 17 '26Sale55.571,892105,14728,975Mar 18 12:00 AM
Cowan ElviaSVP, Finance & CAOMar 11 '26Option Exercise25.925,000129,60096,068Mar 11 12:00 AM
Cowan ElviaSVP, Finance & CAOMar 11 '26Sale58.592,500146,48230,867Mar 11 12:00 AM
Wassil JimCHIEF OPERATING OFFICERMar 10 '26Sale58.887,395435,440166,818Mar 11 12:00 AM
Cowan ElviaSVP, Finance & CAOFeb 26 '26Option Exercise25.9215,432399,99898,568Mar 02 12:00 AM
Dhaliwal Harpreet S.Chief Technical Ops OfficerDec 31 '25Sale46.699,743454,89123,928Jan 02 12:00 AM
Cowan ElviaSVP, FINANCEDec 23 '25Sale47.9211,623556,97114,534Dec 29 12:00 AM
Lukatch HeathDirectorApr 08 '25Option Exercise16.7814,000234,98014,175Apr 10 12:00 AM
GUGGENHIME ANDREWPRESIDENT AND CFOApr 07 '25Option Exercise20.939,554199,966131,950Apr 09 12:00 AM
PICKERING GRANTCHIEF EXECUTIVE OFFICERApr 04 '25Option Exercise8.9641,066367,774518,775Apr 07 12:00 AM
Eydelman MikhailSVP, GEN COUNSEL & CORP SECMar 05 '25Option Exercise21.4110,000214,100144,497Mar 07 12:00 AM
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR